Materia Medica Holding Research

Materia Medica Holding is a prominent Russian pharmaceutical company focused on the research, development, and commercialization of a unique class of drugs termed release-active therapeutics. These products utilize highly diluted antibodies against endogenous proteins to modulate biological pathways, targeting a wide range of conditions including viral infections, neurological disorders, and metabolic diseases. The company's portfolio features several market-leading brands in Russia and the CIS region, such as Anaferon, Ergoferon, and Tenoten. Materia Medica Holding operates integrated R&D and manufacturing facilities that comply with international GMP standards. While its technology is a subject of scientific debate due to the high dilution levels, the company maintains an extensive clinical trial program and a significant presence in the over-the-counter drug market.